secwatch / observer
8-K filed May 24, 2023, 7:59 PM ET CIK 0001839133
leadership confidence high sentiment neutral materiality 0.60

CEO Moshe Gerber resigns; Chairperson Oded Bashan named Interim CEO

IR-Med, Inc.

Executive movements

Machine-extracted from this filing. Every card cites the SEC source. See all recent executive movements.

Departed

Moshe Gerber

Chief Executive Officer
IR-Med, Inc.
Effective
2023-05-21
Successor
Oded Bashan
Filed
May 24, 2023, 7:59 PM ET
pursuant to which MG resigned from his role as Chief Executive Officer of the Companies.
Appointed (interim)

Oded Bashan

Interim Chief Executive Officer
IR-Med, Inc.
Effective
2023-05-21
Filed
May 24, 2023, 7:59 PM ET
Mr. Oded Bashan, the Chairperson and a co-founder of the Company, was appointed as Interim Chief Executive Officer of the Company.

Key facts

Extracted from this filing and checked against the source text.

Executive change SEC 8-K Item 5.02 confidence 0.95

Moshe Gerber resigned as Chief Executive Officer at IR-Med, Inc..

Action
resigned
Role
Chief Executive Officer
Exact text from the filing
pursuant to which MG resigned from his role as Chief Executive Officer of the Companies.
View on SEC.gov
Executive change SEC 8-K Item 5.02 confidence 0.95

Oded Bashan was appointed as Interim Chief Executive Officer at IR-Med, Inc..

Action
appointed
Role
Interim Chief Executive Officer
Exact text from the filing
Mr. Oded Bashan, the Chairperson and a co-founder of the Company, was appointed as Interim Chief Executive Officer of the Company.
View on SEC.gov
Source: SEC EDGAR
accession 0001493152-23-018910
Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.